Virtu KCG Holdings’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Virtu KCG Holdings’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-14,295	Closed	-$328K	–	3664
2016 Q4	$328K	Sell	14,295 -19,526	-58%	-$468K	0.01%	1982
2016 Q3	$883K	Buy	33,821 +11,238	+50%	+$280K	0.02%	811
2016 Q2	$511K	Buy	22,583 +2,127	+10%	+$50.5K	0.01%	1347
2016 Q1	$448K	Sell	20,456 -9,683	-32%	-$221K	0.01%	1311
2015 Q4	$957K	Sell	30,139 -19,094	-39%	-$585K	0.02%	900
2015 Q3	$1.37M	Buy	+49,233	New	+$1.72M	0.02%	659
2015 Q1	–	Sell	-56,393	Closed	-$1.4M	–	3775
2014 Q4	$1.4M	Buy	+56,393	New	+$1.4M	0.02%	659

Other funds holding SBIO

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu KCG Holdings's SBIO Position: Q1 2017 in Review

Virtu KCG Holdings sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2017, closing a stake of 14,295 shares — an estimated $328K sold.

Virtu KCG Holdings first reported a position in SBIO in Q4 2014 and held it in 7 quarters. The position peaked at $1.4M in Q4 2014. 28 funds tracked by Wall St. Rank hold SBIO as of Q1 2017.

Virtu KCG Holdings reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 14,295 ALPS Medical Breakthroughs ETF shares in Q1 2017, an estimated $328K.
Virtu KCG Holdings first reported a position in ALPS Medical Breakthroughs ETF in Q4 2014 and held it in 7 quarters.
Virtu KCG Holdings's ALPS Medical Breakthroughs ETF position peaked at $1.4M in Q4 2014.
28 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.